Health Condition 1: R00-R99- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
Conditions
Interventions
Intervention1: ADMINISTRATION OF HYDROCORTISONE: ADMINISTRATION OF HYDROCORTISONE AT THE TIME OF ADMISSION
Control Intervention1: NIL: NIL
Sponsors
VINOD INGALE
Eligibility
Inclusion criteria
Inclusion criteria: age 1 month to 18 years admission to picu within 24 hours of shock recognition parental consent and patient assent
Exclusion criteria
Exclusion criteria: known primary adrenal insufficiency or chronic steroid therapy immunosuppresive conditions or medications terminal illness with expected survival less than 48 hours previous enrollment in interventional clinical trials inability to obtain informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome measure will be the duration from initiation of therapy to recovery from shock , defined as the time to achieve hemodynamic stabilityTimepoint: At the time of admission | — |
Secondary
| Measure | Time frame |
|---|---|
| Picu stay, mortality,steroid related adverse effectsTimepoint: At the time of discharge | — |
Countries
India
Contacts
Public ContactVinod Ingale
MGM MEDICAL COLLEGE AND HOSPITAL
Outcome results
None listed